CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis
BackgroundIdiopathic pulmonary fibrosis (IPF) has high mortality worldwide. The CD247 molecule (CD247, as known as T-cell surface glycoprotein CD3 zeta chain) has been reported as a susceptibility locus in systemic sclerosis, but its correlation with IPF remains unclear.MethodsDatasets were acquired...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0cade99219af45408e99c8f016a4486c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0cade99219af45408e99c8f016a4486c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0cade99219af45408e99c8f016a4486c2021-11-22T06:38:19ZCD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis1664-322410.3389/fimmu.2021.762594https://doaj.org/article/0cade99219af45408e99c8f016a4486c2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.762594/fullhttps://doaj.org/toc/1664-3224BackgroundIdiopathic pulmonary fibrosis (IPF) has high mortality worldwide. The CD247 molecule (CD247, as known as T-cell surface glycoprotein CD3 zeta chain) has been reported as a susceptibility locus in systemic sclerosis, but its correlation with IPF remains unclear.MethodsDatasets were acquired by researching the Gene Expression Omnibus (GEO). CD247 was identified as the hub gene associated with percent predicted diffusion capacity of the lung for carbon monoxide (Dlco% predicted) and prognosis according to Pearson correlation, logistic regression, and survival analysis.ResultsCD247 is significantly downregulated in patients with IPF compared with controls in both blood and lung tissue samples. Moreover, CD247 is significantly positively associated with Dlco% predicted in blood and lung tissue samples. Patients with low-expression CD247 had shorter transplant-free survival (TFS) time and more composite end-point events (CEP, death, or decline in FVC >10% over a 6-month period) compared with patients with high-expression CD247 (blood). Moreover, in the follow-up 1st, 3rd, 6th, and 12th months, low expression of CD247 was still the risk factor of CEP in the GSE93606 dataset (blood). Thirteen genes were found to interact with CD247 according to the protein–protein interaction network, and the 14 genes including CD247 were associated with the functions of T cells and natural killer (NK) cells such as PD-L1 expression and PD-1 checkpoint pathway and NK cell-mediated cytotoxicity. Furthermore, we also found that a low expression of CD247 might be associated with a lower activity of TIL (tumor-infiltrating lymphocytes), checkpoint, and cytolytic activity and a higher activity of macrophages and neutrophils.ConclusionThese results imply that CD247 may be a potential T cell-derived disease severity and prognostic biomarker for IPF.Yupeng LiShibin ChenXincheng LiXue WangHuiwen LiShangwei NingHong ChenFrontiers Media S.A.articleidiopathic pulmonary fibrosisCD247immune responseinflammation responsebiomarkerprognosisImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
idiopathic pulmonary fibrosis CD247 immune response inflammation response biomarker prognosis Immunologic diseases. Allergy RC581-607 |
spellingShingle |
idiopathic pulmonary fibrosis CD247 immune response inflammation response biomarker prognosis Immunologic diseases. Allergy RC581-607 Yupeng Li Shibin Chen Xincheng Li Xue Wang Huiwen Li Shangwei Ning Hong Chen CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis |
description |
BackgroundIdiopathic pulmonary fibrosis (IPF) has high mortality worldwide. The CD247 molecule (CD247, as known as T-cell surface glycoprotein CD3 zeta chain) has been reported as a susceptibility locus in systemic sclerosis, but its correlation with IPF remains unclear.MethodsDatasets were acquired by researching the Gene Expression Omnibus (GEO). CD247 was identified as the hub gene associated with percent predicted diffusion capacity of the lung for carbon monoxide (Dlco% predicted) and prognosis according to Pearson correlation, logistic regression, and survival analysis.ResultsCD247 is significantly downregulated in patients with IPF compared with controls in both blood and lung tissue samples. Moreover, CD247 is significantly positively associated with Dlco% predicted in blood and lung tissue samples. Patients with low-expression CD247 had shorter transplant-free survival (TFS) time and more composite end-point events (CEP, death, or decline in FVC >10% over a 6-month period) compared with patients with high-expression CD247 (blood). Moreover, in the follow-up 1st, 3rd, 6th, and 12th months, low expression of CD247 was still the risk factor of CEP in the GSE93606 dataset (blood). Thirteen genes were found to interact with CD247 according to the protein–protein interaction network, and the 14 genes including CD247 were associated with the functions of T cells and natural killer (NK) cells such as PD-L1 expression and PD-1 checkpoint pathway and NK cell-mediated cytotoxicity. Furthermore, we also found that a low expression of CD247 might be associated with a lower activity of TIL (tumor-infiltrating lymphocytes), checkpoint, and cytolytic activity and a higher activity of macrophages and neutrophils.ConclusionThese results imply that CD247 may be a potential T cell-derived disease severity and prognostic biomarker for IPF. |
format |
article |
author |
Yupeng Li Shibin Chen Xincheng Li Xue Wang Huiwen Li Shangwei Ning Hong Chen |
author_facet |
Yupeng Li Shibin Chen Xincheng Li Xue Wang Huiwen Li Shangwei Ning Hong Chen |
author_sort |
Yupeng Li |
title |
CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis |
title_short |
CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis |
title_full |
CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis |
title_fullStr |
CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis |
title_full_unstemmed |
CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis |
title_sort |
cd247, a potential t cell–derived disease severity and prognostic biomarker in patients with idiopathic pulmonary fibrosis |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/0cade99219af45408e99c8f016a4486c |
work_keys_str_mv |
AT yupengli cd247apotentialtcellderiveddiseaseseverityandprognosticbiomarkerinpatientswithidiopathicpulmonaryfibrosis AT shibinchen cd247apotentialtcellderiveddiseaseseverityandprognosticbiomarkerinpatientswithidiopathicpulmonaryfibrosis AT xinchengli cd247apotentialtcellderiveddiseaseseverityandprognosticbiomarkerinpatientswithidiopathicpulmonaryfibrosis AT xuewang cd247apotentialtcellderiveddiseaseseverityandprognosticbiomarkerinpatientswithidiopathicpulmonaryfibrosis AT huiwenli cd247apotentialtcellderiveddiseaseseverityandprognosticbiomarkerinpatientswithidiopathicpulmonaryfibrosis AT shangweining cd247apotentialtcellderiveddiseaseseverityandprognosticbiomarkerinpatientswithidiopathicpulmonaryfibrosis AT hongchen cd247apotentialtcellderiveddiseaseseverityandprognosticbiomarkerinpatientswithidiopathicpulmonaryfibrosis |
_version_ |
1718418084497195008 |